Research Phase

Article
Researchers reveal how cancer shuts down T cells
|DDN Staff

Researchers reveal how cancer shuts down T cells

New study shows tumor cells eat up methionine, depriving T cells

View Article
Article
At the vanguard of metabo-oncology
|Jeffrey Bouley

At the vanguard of metabo-oncology

Drug candidate SDX-7320, which has already undergone Phase 1 study, offsets hyperglycemia caused by PI3K/Akt/mTOR cancer therapies and restores insulin sensitivity, according to recent preclinical research

View Article

Latest

Popular Topics
Discovery
Preclinical Research
Clinical Research
Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all the latest DDN news!

Latest Issue's Magazine Cover

Latest Issue  

• Volume 16 • Issue 10 • November 2020

November 2020

November 2020 Issue